StemGen SGNI · USD

Its shares trade under the ticker SGNI. It has been listed since 11 January 2008. In the fiscal year to 30 June 2021, it reported revenue of $39,000 and a net loss of $433,000. At that date it held total assets of $401,643 and shareholders' equity of −$1.3m.

StemGen, Inc. engages in the acquisition of a company with a well developed business plan to participate in an emerging industry. The company is headquartered in Angleton, Texas. The company went IPO on 2008-01-11. The firm searches for targets that have a market-ready product or process that requires additional assistance to move ahead in their market. The firm holds 100% of the membership interests in Global Visionary Investments LLC (Global Visionary), which is a business advisory services company. Global Visionary has a license with SOKAP, which provides business intelligence in deal sourcing and target vetting. Through their geo-targeting software platform, the acquisition targets have the opportunity to market their products and services in a different way through licensing specific territories for the sale of their products or services.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Simon DawsonPresident, Chief Executive Officer, Treasurer, Secretary, Director, since 2019$18,500
• Mr. Ron McNairChief Financial Officer
• Mr. Erik StromanExecutive Vice President - Sales, Marketing and Business Development
• Ms. Barbara BurnsChief Communications Officer
• Mr. Sean TabatabaiChief Strategy Officer

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.